EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.30−0.01 (-3.80%)
Close on Nov 17, 2026Market cap $25.51MP/E –Yield –
EyePoint total assets
Total assets on the balance sheet at the end of each period.
EyePoint's total assets was $228.19M at Jun 30, 2026. For fiscal 2025 it was $364.00M, down 13.0% from the year before. Over ten years it grew 32.0% a year on average. The highest annual figure on record is $418.47M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $364.00M | -13.0% |
| FY2024 | Dec 31, 2024 | $418.47M | +17.8% |
| FY2023 | Dec 31, 2023 | $355.18M | +96.9% |
| FY2022 | Dec 31, 2022 | $180.36M | -31.5% |
| FY2021 | Dec 31, 2021 | $263.37M | +187.2% |
| FY2020 | Dec 31, 2020 | $91.72M | +28.0% |
| FY2018 | Jun 30, 2018 | $71.67M | +283.7% |
| FY2017 | Jun 30, 2017 | $18.68M | -40.9% |
| FY2016 | Jun 30, 2016 | $31.62M | -2.3% |
| FY2015 | Jun 30, 2015 | $32.37M | +42.8% |
| FY2014 | Jun 30, 2014 | $22.67M | +39.5% |
| FY2013 | Jun 30, 2013 | $16.25M | -21.1% |
| FY2012 | Jun 30, 2012 | $20.60M | -56.3% |
| FY2011 | Jun 30, 2011 | $47.11M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $228.19M | -24.2% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $288.22M | -20.5% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | $364.00M | -13.0% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | $251.70M | -16.4% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | $301.15M | -7.1% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | $362.56M | +10.1% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | $418.47M | +17.8% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $300.92M | +88.0% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $324.25M | +84.6% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | $329.25M | +113.0% |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | $355.18M | +96.9% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $160.04M | -27.4% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | $175.66M | -24.8% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | $154.59M | -36.8% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | $180.36M | -31.5% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | $220.49M | +31.0% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | $233.43M | +30.5% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | $244.56M | +30.7% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | $263.37M | +187.2% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $168.25M | +119.1% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | $178.82M | +156.6% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | $187.14M | +133.1% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | $91.72M | +28.0% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | $76.79M | +53.1% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | $69.69M | +390.8% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $80.29M | +502.5% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $71.67M | +283.7% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $50.16M | +186.5% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $14.20M | -28.1% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $13.33M | -46.5% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $18.68M | -40.9% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $17.51M | -51.6% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $19.75M | -17.6% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | $24.93M | -9.2% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | $31.62M | -2.3% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | $36.17M | +1.3% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | $23.95M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | $27.46M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | $32.37M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | $35.70M | – |
See a number that looks wrong?